PROTEOTECH
ProteoTech, Inc., also known as Proteoglycan Technologies, Inc., operates as a drug development company in the United States. The company offers therapeutics and diagnostics for amyloid diseases. Its products include Exebryl-1, a molecule compound to prevent the formation and accumulation of the soluble and insoluble forms of beta-amyloid protein, as well as amyloid plaques found in Alzheimer's brains of disease victims; PeptiClere, a nasal spray for the treatment of Alzheimer's disease; Synuclere for the treatment of Parkinson's disease; and Systebryl, a small molecule compound for the treatment of systemic amyloidosis associated with type 2 diabetes. ProteoTech, Inc. was founded in 1996 and is headquartered in Kirkland, Washington.
PROTEOTECH
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
1996-01-01
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.proteotech.com
Total Employee:
1+
Status:
Active
Contact:
4258238508
Email Addresses:
[email protected]
Total Funding:
10.54 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Similar Organizations
Ferrologix
Ferrologix is a scientific research and development company that provides cellular therapy and cell separation services.
Current Employees Featured
Founder
Official Site Inspections
http://www.proteotech.com
- Host name: ec2-13-216-111-180.compute-1.amazonaws.com
- IP address: 13.216.111.180
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
